Cosmo Pharmaceuticals S.p.A Stock Swiss Exchange
Equities
IT0004167463
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
|
Sales 2024 * | 264M 282M 254M | Sales 2025 * | 242M 259M 233M | Capitalization | 1.17B 1.25B 1.13B |
---|---|---|---|---|---|
Net income 2024 * | 124M 133M 119M | Net income 2025 * | 76M 81.38M 73.12M | EV / Sales 2024 * | 3.99 x |
Net cash position 2024 * | 120M 128M 115M | Net cash position 2025 * | 210M 225M 202M | EV / Sales 2025 * | 3.97 x |
P/E ratio 2024 * |
9.53
x | P/E ratio 2025 * |
12.8
x | Employees | - |
Yield 2024 * |
2.88% | Yield 2025 * |
1.05% | Free-Float | 44.36% |
Latest transcript on Cosmo Pharmaceuticals S.p.A
Managers | Title | Age | Since |
---|---|---|---|
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chairman | 61 | 05-12-31 | |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 69 | 96-12-31 | |
Director/Board Member | 69 | 12-03-31 | |
Chairman | 61 | 05-12-31 |
1st Jan change | Capi. | |
---|---|---|
+56.00% | 819B | |
-6.82% | 351B | |
+17.04% | 329B | |
+9.90% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.25% | 168B | |
-2.83% | 158B |